Morphine Sulfate Solution
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-26-R-0017
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
The Defense Logistics Agency (DLA) Troop Support, operating under the Department of Defense, has issued a presolicitation notice for a forthcoming national requirements contract for Morphine Sulfate Solution. This procurement is intended to establish a reliable, domestic supply source for various morphine sulfate formulations, supporting the needs of the Department of War, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons. The contract will facilitate purchases through the DLA and VA prime vendor programs, ensuring consistent access to these critical pharmaceutical products.
The scope of the contract encompasses multiple presentations of morphine sulfate, including:
- Injection syringes: 2MG/ML and 4MG/ML, as well as intravenous syringes in 2MG/ML and 10MG/ML strengths, packaged in packs of 10.
- Injection solution vials: 2MG/ML, 4MG/ML, and 10MG/ML, and intravenous solution vials in 4MG/ML and 10MG/ML strengths, packaged in boxes of 25.
The procurement is strictly limited to domestic sources, requiring that both the Active Pharmaceutical Ingredients (API) and Final Dosage Forms (FDF) be manufactured within the United States. Competition will be open to all qualified domestic manufacturers, with the aim of fostering robust supply chain security and compliance with federal sourcing requirements.
The contract will be structured as a firm-fixed price, requirements type agreement, featuring a one-year base period and four one-year option periods. This arrangement is designed to provide flexibility and continuity of supply over a potential five-year lifecycle. Annual usage estimates for each item will be detailed in the Schedule of Supplies section of the solicitation, enabling prospective contractors to assess production and distribution requirements.
This procurement is classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing, 2022 version) and Product Service Code 6505, reflecting its focus on commercial pharmaceutical products. The solicitation will be conducted in accordance with FAR Part 12, emphasizing commercial item acquisition procedures.
Interested parties are encouraged to monitor the DLA Bid Board System (DIBBS) and SAM.gov for the official solicitation, which is projected to be released in October or November of 2026. However, DLA reserves the right to adjust the solicitation timeline as needed. All qualified sources may submit proposals, which will be duly considered by the agency.
For further information or to address questions and comments, contractors may contact Christopher Newman at (445) 737-7371 or [email protected]. Jason C. Wray is also available at (445) 737-6304 or [email protected]. Interested vendors are advised to set up automated notifications for updates related to this opportunity.
This presolicitation notice represents a significant opportunity for domestic pharmaceutical manufacturers specializing in injectable opioid analgesics to support federal healthcare and correctional institutions. The contract’s requirements for domestic manufacturing, firm-fixed pricing, and multi-year options underscore the government’s commitment to supply chain integrity and long-term partnership with qualified suppliers.